Abstract
BACKGROUND: Radiolabeling is a technique that involves attaching radioactive isotopes to molecules, allowing for their tracking and analysis in biological systems. Radiolabeled D-glucose and its derivatives have a very prominent role in exploring metabolic pathways, the enzymatic system, and measuring the flow of the metabolites through biochemical reactions, as accumulation or deficiency of metabolites occurs along with metabolic disorders. Glucose as the main source of energy in the body is involved in different metabolic pathways like glycolysis, pentose phosphate pathway, and tricarboxylic acid cycle. Various derivatives of glucose are labeled at different positions by (14)C and (3)H. The aim of this review is to summarize some of the most significant aspects of the use of different radiolabeled D-glucose, 2-deoxy-D-glucose, and methyl-α-D-glucopyranoside. MAIN BODY: This review focuses on the application of radiolabeled glucose derivatives in studying glucose transport systems, metabolic pathways, enzyme activity, and glucose utilization across various tissues. It highlights their role in understanding disease mechanisms in diabetes, cancer, heart failure, and metabolic disorders, and the impact of pharmacological agents and environmental pollutants. CONCLUSION: In conclusion, radiolabeled glucose derivatives are invaluable tools for studying glucose metabolism across various tissues and organs. They provide critical insights into metabolic dysfunctions, disease mechanisms, and therapeutic interventions, aiding in the development of targeted treatments for conditions like diabetes, cancer, and cardiovascular diseases.